Was it Worth It? Response Data from >650 United States and International Participants in Chemoprevention Trials
{{output}}
The aim was to assess whether subject's participation in early-phase chemoprevention trials was satisfactory and to identify features associated with subjects' satisfaction. Thirteen trials that investigated a range of candidate agents from 2006-2021 by the ... ...
